1,670
Participants
Start Date
August 15, 2012
Primary Completion Date
September 2, 2015
Study Completion Date
December 6, 2016
Placebo
Form=solution for injection, route=subcutaneous use; every 2 weeks from Week 0 through Week 50.
Placebo
Form=solution for injection, route=subcutaneous use; Weeks 2, 6, and every 4 weeks through Week 104.
Sirukumab
Type=exact, unit=mg, number=50 or 100, form=solution for injection, route=subcutaneous use; every 2 weeks for 100 mg and every 4 weeks for 50 mg, Week 52 through Week 104.
Sirukumab
Type=exact, unit=mg, number=100, form=solution for injection, route=subcutaneous use; Weeks 0, 2, and every 2 weeks through Week 104.
Sirukumab
Type=exact, unit=mg, number=50, form=solution for injection, route=subcutaneous use; Weeks 0, 4, and every 4 weeks through Week 104.
Glendale
Mesa
Peoria
Phoenix
Covina
El Cajon
Glendale
Hemet
Huntington Beach
La Jolla
La Palma
Whittier
Aventura
Brandon
Daytona Beach
Lake Mary
Naples
Palm Harbor
Tampa
Zephyrhills
Indianapolis
Cedar Rapids
Bowling Green
Monroe
Wheaton
Eagan
Springfield
St Louis
Omaha
Albuquerque
Brooklyn
Plainview
Charlotte
Cincinnati
Middleburg Heights
Edmond
Tulsa
Duncansville
Wyomissing
Carrollton
Corpus Christi
Dallas
Houston
Lubbock
Mesquite
Kennewick
Beckley
Clarksburg
Plovdiv
Sofia
Victoria
Winnipeg
Ottawa
Burlington
Edmonton
Rancagua
Santiago
Valdivia
Bogotá
Chía
Medellín
Osijek
Rijeka
Zagreb
Ayauta-Gun
Bunkyō City
Fukuoka
Higashihiroshima
Izumo
Kagoshima
Katō
Kawagoe
Kita-Gun
Kumamoto
Kurume
Miyazaki
Nagano
Nagasaki
Nagoya
Osaka
Sapporo
Sasebo
Shimonoseki
Shimotsuke
Shinjuku-Ku
Sumida-Ku
Takaoka,Toyama
Takasaki
Tokorozawa
Tokushima
Tomishiro
Tsu
Ureshino
Yokohama
Alytus
Kaunas
Klaipėda
Šiauliai
Kuala Lumpur
Kuching
Cuernavaca
Guadalajara
Juárez
Mexicali
Mexico City
Mérida
México
Morelia
San Luis de Potosi
Bialystok
Bydgoszcz
Elblag
Lublin
Poznan
Ustroń
Warsaw
Bucharest
Cluj-Napoca
Iași
Kemerovo
Moscow
Novosibirsk
Orenburg
Ryazan
Saint Petersburg
Saratov
Smolensk
Ulyanovsk
Yaroslavl
Belgrade
Kragujevac
Niška Banja
Cape Town
Port Elizabeth
Pretoria
Busan
Daegu
Daejeon
Gwangju
Incheon
Jeonju
Namdong-Gu
Seongnam-si
Seoul
Suwon
Kaohsiung City
Taichung
Taipei
Donetsk
Kharkiv
Kiev
Kyiv
Odesa
Sympheropol
Vinnytsia
Zaporizhzhia
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY